Published in Genome Res on September 02, 2011
Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell (2014) 1.72
Accurate Breakpoint Mapping in Apparently Balanced Translocation Families with Discordant Phenotypes Using Whole Genome Mate-Pair Sequencing. PLoS One (2017) 1.37
Large inverted duplications in the human genome form via a fold-back mechanism. PLoS Genet (2014) 0.91
Deciphering the pathogenic consequences of chromosomal aberrations in human genetic disease. Mol Cytogenet (2014) 0.87
Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer. J Pathol (2013) 0.86
The clinical impact of chromosomal rearrangements with breakpoints upstream of the SOX9 gene: two novel de novo balanced translocations associated with acampomelic campomelic dysplasia. BMC Med Genet (2013) 0.85
Complex structural rearrangement features suggesting chromoanagenesis mechanism in a case of 1p36 deletion syndrome. Mol Genet Genomics (2014) 0.80
Unbalanced translocations arise from diverse mutational mechanisms including chromothripsis. Genome Res (2015) 0.80
High throughput sequencing approaches to mutation discovery in the mouse. Mamm Genome (2012) 0.76
Integration of Lupinus angustifolius L. (narrow-leafed lupin) genome maps and comparative mapping within legumes. Chromosome Res (2016) 0.76
Chromothripsis after Stumbling through DNA Replication. Mol Syndromol (2015) 0.75
Familial complex chromosome rearrangement (CCR) involving 5 breakpoints on chromosomes 1, 3 and 13 in a severe oligozoospermic patient. J Assist Reprod Genet (2013) 0.75
Reciprocal Translocation Carrier Diagnosis in Preimplantation Human Embryos. EBioMedicine (2016) 0.75
Derivative chromosome 11 in a child resulting from a complex rearrangement involving chromosomes 3, 6 and 11 in father: Significance of parental karyotyping. Indian J Hum Genet (2013) 0.75
Molecular characterization of ring chromosome 18 by low-coverage next generation sequencing. BMC Med Genet (2015) 0.75
Genomic Investigation of Balanced Chromosomal Rearrangements in Patients with Abnormal Phenotypes. Mol Syndromol (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
Global variation in copy number in the human genome. Nature (2006) 57.50
Integrative genomics viewer. Nat Biotechnol (2011) 42.83
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol (2009) 27.17
Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55
Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55
Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet (2004) 8.85
Structural variation in the human genome and its role in disease. Annu Rev Med (2010) 7.85
A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet (2003) 6.82
Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med (2010) 6.08
Natural mutagenesis of human genomes by endogenous retrotransposons. Cell (2010) 5.50
Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci U S A (2002) 5.18
Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet (2001) 4.77
LINE-1 retrotransposition activity in human genomes. Cell (2010) 4.60
Mechanisms for human genomic rearrangements. Pathogenetics (2008) 4.54
De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. Am J Hum Genet (1991) 4.04
Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60
Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med (2010) 3.12
Mental retardation associated with "balanced" chromosome rearrangements. Am J Hum Genet (1977) 3.06
Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet (2002) 2.96
Mapping translocation breakpoints by next-generation sequencing. Genome Res (2008) 2.73
SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data. Bioinformatics (2010) 2.63
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res (2010) 1.94
The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes. J Med Genet (2005) 1.94
A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein dynamically regulated in brain. Proc Natl Acad Sci U S A (2003) 1.93
The frequency and mutation rate of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet (1983) 1.64
Long-range regulation at the SOX9 locus in development and disease. J Med Genet (2009) 1.62
Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann N Y Acad Sci (2009) 1.44
Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes. Genome Res (2011) 1.37
Physical mapping of a translocation breakpoint in neurofibromatosis. Science (1989) 1.27
Cryptic genomic imbalances in patients with de novo or familial apparently balanced translocations and abnormal phenotype. Mol Cytogenet (2008) 1.23
Breakpoint analysis of balanced chromosome rearrangements by next-generation paired-end sequencing. Eur J Hum Genet (2009) 1.22
The discovery of human genetic variations and their use as disease markers: past, present and future. J Hum Genet (2010) 1.17
Two novel translocation breakpoints upstream of SOX9 define borders of the proximal and distal breakpoint cluster region in campomelic dysplasia. Clin Genet (2007) 1.07
Cytogenetics and genetics of human cancer: methods and accomplishments. Cancer Genet Cytogenet (2010) 0.92
Molecular characterization of a balanced chromosome translocation in psoriasis vulgaris. Clin Genet (2006) 0.86
Delineation of the proximal 3q microdeletion syndrome. Am J Med Genet A (2008) 0.84
Delayed membranous ossification of the cranium associated with familial translocation (2;3)(p15;q12). Am J Med Genet (2000) 0.81
Finding the missing heritability of complex diseases. Nature (2009) 67.95
The human disease network. Proc Natl Acad Sci U S A (2007) 19.58
Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res (2003) 14.79
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet (2010) 13.70
McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res (2008) 12.83
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36
Prepublication data sharing. Nature (2009) 12.24
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest (2008) 10.74
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2002) 9.50
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med (2010) 8.64
Hypothalamic mTOR signaling regulates food intake. Science (2006) 8.62
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science (2009) 7.80
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A (2005) 7.21
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell (2003) 6.76
A new face and new challenges for Online Mendelian Inheritance in Man (OMIM®). Hum Mutat (2011) 6.25
S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol (2004) 6.00
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA (2003) 5.08
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab (2006) 4.98
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science (2010) 4.81
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. J Clin Oncol (2011) 4.53
Completing the map of human genetic variation. Nature (2007) 4.38
Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet (2010) 4.29
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol (2006) 4.24
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol (2003) 4.20
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation (2004) 4.13
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab (2010) 4.08
A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82
The characterization of twenty sequenced human genomes. PLoS Genet (2010) 3.72
MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem (2007) 3.71
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med (2007) 3.66
Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation. Cell (2005) 3.59
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest (2010) 3.47
Lessons from the inquiry into Obstetrics and Gynaecology services at King Edward Memorial Hospital 1990-2000. Aust Health Rev (2003) 3.46
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
The roles of nature and nurture in the recruitment and retention of primary care physicians in rural areas: a review of the literature. Acad Med (2002) 3.42
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med (2007) 3.36
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2007) 3.32
Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol (2004) 3.20
The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions. Am J Med Genet A (2012) 3.12
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol (2009) 2.97
Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab (2008) 2.96
Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev (2002) 2.87
Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry (2007) 2.84
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells. Cancer Res (2004) 2.64
Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J Cell Biol (2002) 2.46
Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A (2002) 2.38
Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet (2010) 2.38
Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays (2002) 2.37
Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 2.34
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res (2002) 2.33
dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat Cell Biol (2002) 2.31
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol (2009) 2.30
Recurrent DNA inversion rearrangements in the human genome. Proc Natl Acad Sci U S A (2007) 2.29
Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22
DNA methylation regulates MicroRNA expression. Cancer Biol Ther (2007) 2.21
Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis (2010) 2.21
PhenoDB: a new web-based tool for the collection, storage, and analysis of phenotypic features. Hum Mutat (2013) 2.13
Statin use associates with a lower incidence of acute kidney injury after major elective surgery. J Am Soc Nephrol (2011) 2.11
Peroxisome biogenesis disorders. Annu Rev Genomics Hum Genet (2003) 2.09
Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med (2007) 2.04
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum (2004) 2.04
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data. J Clin Oncol (2008) 2.01
The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett (2006) 1.97
Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95
Exploring massive, genome scale datasets with the GenometriCorr package. PLoS Comput Biol (2012) 1.89
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis (2011) 1.88
GeneDesign: rapid, automated design of multikilobase synthetic genes. Genome Res (2006) 1.87
Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery (2005) 1.87
S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem (2008) 1.87
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol (2012) 1.80
Genome-wide consequences of deleting any single gene. Mol Cell (2013) 1.76
S6K1 plays a critical role in early adipocyte differentiation. Dev Cell (2010) 1.74
S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol (2009) 1.74
Signaling control of mRNA translation in cancer pathogenesis. Oncogene (2004) 1.71
Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology (2006) 1.71
Otogenic intracranial complications. a 7-year retrospective review. Am J Otolaryngol (2006) 1.69
Factors associated with internal hip rotation gait in patients with cerebral palsy. J Pediatr Orthop (2006) 1.67
Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem (2002) 1.66
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res (2013) 1.66
New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene. Hum Mutat (2015) 1.64
Genetic background controls tumor development in PTEN-deficient mice. Cancer Res (2006) 1.63
Early complications in proximal humerus fractures (OTA Types 11) treated with locked plates. J Orthop Trauma (2008) 1.62
Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am (2006) 1.61
Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.60
A novel presentation of DYT 16: acute onset in infancy and association with MRI abnormalities. Mov Disord (2013) 1.58